At the conclusion of these activities, participants will be able to:
1. Identify the impact of race and cultural barriers for ethnic minorities on medical clinical care specific to advanced prostate cancer.
2. Evaluate financial toxicity as a barrier to optimal patient care specific to advanced prostate cancer.
3. Incorporate culturally sensitive communications to ensure quality care and reduce biases across diverse patient populations.
This series is supported by independent educational grants from:
Myovant Sciences LTD
Pfizer, Inc.